NMC Advertising Guidelines 2026: Complete Legal Guide for Doctors and Hospitals

What happened on 6 October 2026?

The National Medical Commission issued public notice R-13014/01/2024-Ethics with the Guidelines on Ethical Advertising and Public Communication by Hospitals/Medical Institutions and Registered Medical Practitioners. The notice says the guidelines apply with immediate effect. That is what the notice states; the legal force of particular sanctions and institutional applications must still be read against enabling legislation and other regulations. S1

A doctor asking whether an educational Reel remains possible and a hospital asking whether it may publish emergency-service hours are not asking the same question. The answer begins by identifying the speaker, the content, the commercial context and the law that applies to that speaker.

Which legal instruments have to be read together?

The NMC Act, 2019 supplies the broader statutory structure. For registered medical practitioners (RMPs), the Indian Medical Council Professional Conduct Regulations, 2002 remain important following the August 2023 amendment that held the 2023 RMP Professional Conduct Regulations in abeyance and adopted the 2002 code. The October 2026 guidelines refer back to that framework. Separate consumer protection, data and establishment laws may apply to the same communication. S2 S3 S4

These are cumulative questions, not a contest in which one guideline automatically cancels every other applicable rule. A marketing-platform approval, for example, establishes nothing about NMC ethics compliance.

The RMP–hospital distinction

Clause 8.1 imposes far-reaching restrictions on individual RMP promotion, solicitation, product endorsement, patient-result publicity, commercial referrals, rankings and manipulated online reputation. Clause 8.2 recognises specified communications, such as factual professional announcements and qualifying educational work. By contrast, clause 8.3 allows hospitals to communicate objective, verifiable information about their name, location, departments, facilities, equipment, services, emergency care, accreditation and charges, subject to its own restrictions. S1

A hospital listing a verified CT facility is not necessarily doing the same thing as a physician announcing a guaranteed cure. Equally, placing a named practitioner's promotional claims on an institutional account does not automatically resolve the practitioner's restrictions.

Four recurring high-risk formats

Patient testimonials and before–after material. Clauses 6.1–6.3 distinguish patient privacy, consent and the underlying permissibility of promotion. In particular, clause 6.2 says consent alone cannot make an otherwise prohibited testimonial permissible. Clause 8.1(v) addresses promotional cases and outcome displays. S1

AI-generated commercial promotion. Clause 7.2 begins with broad prohibitory language and then addresses false synthetic patients, outcomes, representations, disclosure and data entered into AI tools. Do not assume that labelling an AI creative legalises commercial AI promotion. S1

Superlatives and guarantees. Phrases such as 'best doctor', '100% success' or 'risk-free surgery' trigger relevant RMP or institution-specific restrictions and misleading-claim scrutiny. The actual assertion, basis and speaker matter. S1 S5

Patient procurement. Clauses 8.1(vii)–(viii) address commissions and payment arrangements linked to procuring or referring individual patients. Merely describing a referral fee as an agency retainer is not decisive. S1

What remains useful and constructive?

A responsible communication programme can still prioritise verified hospital information, timely service availability, medically accurate public health education, clear charges where lawfully disclosed, independent scientific information, suitable clinical warnings and accessible explanations of procedure limitations.

The safer operational sequence is to check who speaks, what is claimed, what proof exists, who is paying, whether a patient can be identified, and what page or lead form the viewer reaches next. These are recommended review steps, not an NMC-issued certification protocol.

Important unresolved issues

The guidelines describe disciplinary gradations and appeals in clauses 10–11. The exact legal basis of individual penalties and the extent of direct authority over non-RMP institutions require verification under the NMC Act and applicable law; neither automatic validity nor invalidity should be asserted from the notice alone. S1 S4

Responsible first actions

Inventory public posts, website doctor profiles, sponsored ads, patient stories, AI assets and agency contracts. Preserve evidence and publication dates. Prioritise objective corrections where misleading claims or fabricated endorsements are found. Create a publication review log with clinical, legal and marketing sign-off proportional to the risk.